Fig. 2

a Kaplan-Meier estimates of disease-free survival in the 113 patients systemically untreated (– CT), according to low, intermediate, and high Prosigna risk of recurrence (ROR) scores. b Kaplan-Meier estimates of overall survival
a Kaplan-Meier estimates of disease-free survival in the 113 patients systemically untreated (– CT), according to low, intermediate, and high Prosigna risk of recurrence (ROR) scores. b Kaplan-Meier estimates of overall survival